Breaking News Instant updates and real-time market news.

ITMR

Itamar Medical

$21.60 /

+0.76 (+3.65%)

09:20
10/13/20
10/13
09:20
10/13/20
09:20

Piper Sandler 'encouraged' by Itamar results, recommends owning shares

Piper Sandler analyst Matt O'Brien reiterates an Overweight rating on Itamar Medical with a $26 price target following this morning's preliminary Q3 sales results and reinstated fiscal 2020 guidance. While not much detail was provided, management was clear that underlying fundamentals were strong, O'Brien tells investors in a research note. The analyst remains constructive on the longer-term opportunities ahead of Itamar and the "momentum being delivered in the core sleep market." He's "encouraged" by the Q3 preliminary performance and recommends investors own the stock.

  • 31

    Jan

ITMR Itamar Medical
$21.60 /

+0.76 (+3.65%)

08/17/20 H.C. Wainwright
Itamar Medical price target raised to $28 from $21 at H.C. Wainwright
08/11/20 Piper Sandler
Itamar Medical pullback an opportunity to build positions, says Piper Sandler
06/18/20 Cowen
Itamar Medical price target raised to $27 from $20 at Cowen
06/12/20 SVB Leerink
Itamar Medical initiated with an Outperform at SVB Leerink

TODAY'S FREE FLY STORIES

Recommendations
Fifth Third price target raised to $47 from $44 at Citi » 06:19
10/20/21
10/20
06:19
10/20/21
06:19
FITB

Fifth Third

$43.92 /

-0.155 (-0.35%)

Citi analyst Jill Shea…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FITB Fifth Third
$43.92 /

-0.155 (-0.35%)

FITB Fifth Third
$43.92 /

-0.155 (-0.35%)

07/19/21 Odeon Capital
Fifth Third downgraded to Hold from Buy at Odeon Capital
07/16/21 Citi
Fifth Third assumed with a Neutral at Citi
07/06/21 Keefe Bruyette
Fifth Third assumed with a Market Perform at Keefe Bruyette
06/03/21 Baird
Fifth Third price target raised to $44 from $39 at Baird
FITB Fifth Third
$43.92 /

-0.155 (-0.35%)

FITB Fifth Third
$43.92 /

-0.155 (-0.35%)

FITB Fifth Third
$43.92 /

-0.155 (-0.35%)

Recommendations
Halliburton price target raised to $30 from $28 at Citi » 06:18
10/20/21
10/20
06:18
10/20/21
06:18
HAL

Halliburton

$26.10 /

+0.1 (+0.38%)

Citi analyst Scott Gruber…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HAL Halliburton
$26.10 /

+0.1 (+0.38%)

HAL Halliburton
$26.10 /

+0.1 (+0.38%)

10/15/21 Northland
Northland would use potential weakness in oil services 'big 3' to add exposure
10/12/21 Coker Palmer
Halliburton upgraded to Outperform from Sector Perform at Coker Palmer
09/13/21 Citi
Citi positive on oilfield services, upgrades Liberty to Buy, RPC to Neutral
09/08/21 RBC Capital
Halliburton assumed with an Outperform at RBC Capital
HAL Halliburton
$26.10 /

+0.1 (+0.38%)

HAL Halliburton
$26.10 /

+0.1 (+0.38%)

HAL Halliburton
$26.10 /

+0.1 (+0.38%)

HAL Halliburton
$26.10 /

+0.1 (+0.38%)

Hot Stocks
Largo Resources lowers 2021 production and sales guidance » 06:18
10/20/21
10/20
06:18
10/20/21
06:18
LGO

Largo Resources

$11.55 /

+0.16 (+1.40%)

Lowers 2021 V2O5…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LGO Largo Resources
$11.55 /

+0.16 (+1.40%)

LGO Largo Resources
$11.55 /

+0.16 (+1.40%)

08/16/21 RBC Capital
Largo Resources price target lowered to C$24 from C$25 at RBC Capital
06/30/21 RBC Capital
Largo Resources price target raised to C$25 from C$20 at RBC Capital
06/14/21 H.C. Wainwright
Largo Resources price target raised to $24 from $20 at H.C. Wainwright
04/19/21 Morgan Stanley
Largo Resources upgraded to Overweight from Equal Weight at Morgan Stanley
LGO Largo Resources
$11.55 /

+0.16 (+1.40%)

Downgrade
Compass Minerals downgraded to Underperform from Market Perform at BMO Capital » 06:18
10/20/21
10/20
06:18
10/20/21
06:18
CMP

Compass Minerals

$73.00 /

-0.15 (-0.21%)

BMO Capital analyst Joel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CMP Compass Minerals
$73.00 /

-0.15 (-0.21%)

CMP Compass Minerals
$73.00 /

-0.15 (-0.21%)

09/30/21 Monness Crespi
Monness Crespi upgrades Compass Minerals to Buy on undervalued lithium assets
09/30/21 Monness Crespi
Compass Minerals upgraded to Buy from Neutral at Monness Crespi
08/17/21
Fly Intel: Top five analyst upgrades
08/17/21 JPMorgan
Compass Minerals upgraded to Neutral from Underweight at JPMorgan
CMP Compass Minerals
$73.00 /

-0.15 (-0.21%)

CMP Compass Minerals
$73.00 /

-0.15 (-0.21%)

Downgrade
Deutsche Bank downgrades Netflix on valuation, keeps $590 price target » 06:17
10/20/21
10/20
06:17
10/20/21
06:17
NFLX

Netflix

$639.47 /

+1.62 (+0.25%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$639.47 /

+1.62 (+0.25%)

NFLX Netflix
$639.47 /

+1.62 (+0.25%)

06:11 Today Deutsche Bank
Netflix downgraded to Hold from Buy at Deutsche Bank
04:58 Today Piper Sandler
Netflix Q4 content slate 'still looks compelling,' says Piper Sandler
04:51 Today Pivotal Research
Netflix price target raised to $750 from $700 at Pivotal Research
10/19/21 Truist
Netflix's Q3 results 'very solid', says Truist
NFLX Netflix
$639.47 /

+1.62 (+0.25%)

NFLX Netflix
$639.47 /

+1.62 (+0.25%)

NFLX Netflix
$639.47 /

+1.62 (+0.25%)

NFLX Netflix
$639.47 /

+1.62 (+0.25%)

Hot Stocks
Switzerland's FINMA concludes proceedings against Credit Suisse » 06:16
10/20/21
10/20
06:16
10/20/21
06:16
CS

Credit Suisse

$10.61 /

+0.15 (+1.43%)

Credit Suisse seriously…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

10/19/21 Kepler Cheuvreux
Credit Suisse upgraded to Buy from Hold at Kepler Cheuvreux
09/17/21 JPMorgan
Credit Suisse price target lowered to CHF 11.30 from CHF 11.60 at JPMorgan
08/12/21 Citi
Credit Suisse removed from EMEA Focus List at Citi
07/30/21 Barclays
Credit Suisse price target raised to CHF 12.50 from CHF 12 at Barclays
CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

Hot Stocks
Largo Resources reports 3Q V205 production up 5% y-o-y to 3,260 tons » 06:15
10/20/21
10/20
06:15
10/20/21
06:15
LGO

Largo Resources

$11.55 /

+0.16 (+1.40%)

Largo Resources reported…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LGO Largo Resources
$11.55 /

+0.16 (+1.40%)

LGO Largo Resources
$11.55 /

+0.16 (+1.40%)

08/16/21 RBC Capital
Largo Resources price target lowered to C$24 from C$25 at RBC Capital
06/30/21 RBC Capital
Largo Resources price target raised to C$25 from C$20 at RBC Capital
06/14/21 H.C. Wainwright
Largo Resources price target raised to $24 from $20 at H.C. Wainwright
04/19/21 Morgan Stanley
Largo Resources upgraded to Overweight from Equal Weight at Morgan Stanley
LGO Largo Resources
$11.55 /

+0.16 (+1.40%)

Downgrade
Western Union downgraded to Neutral from Buy at BTIG » 06:14
10/20/21
10/20
06:14
10/20/21
06:14
WU

Western Union

$20.17 /

-1.135 (-5.33%)

BTIG analyst Mark Palmer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WU Western Union
$20.17 /

-1.135 (-5.33%)

WU Western Union
$20.17 /

-1.135 (-5.33%)

10/14/21 Susquehanna
Western Union price target lowered to $23 from $26 at Susquehanna
09/27/21
Fly Intel: Top five analyst upgrades
09/27/21 Citi
Western Union upgraded to Buy from Neutral at Citi
07/16/21 Susquehanna
Western Union Digital undervalued by investors, says Susquehanna
WU Western Union
$20.17 /

-1.135 (-5.33%)

WU Western Union
$20.17 /

-1.135 (-5.33%)

WU Western Union
$20.17 /

-1.135 (-5.33%)

Initiation
Cyclerion Therapeutics initiated with a Buy at Truist » 06:13
10/20/21
10/20
06:13
10/20/21
06:13
CYCN

Cyclerion Therapeutics

/

+

Truist analyst Joon Lee…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CYCN Cyclerion Therapeutics
/

+

CYCN Cyclerion Therapeutics
/

+

09/24/21 Cantor Fitzgerald
Cyclerion Therapeutics initiated with an Overweight at Cantor Fitzgerald
CYCN Cyclerion Therapeutics
/

+

Downgrade
Ascendis Pharma downgraded to Neutral from Buy at BofA » 06:13
10/20/21
10/20
06:13
10/20/21
06:13
ASND

Ascendis Pharma

$153.36 /

-2.89 (-1.85%)

BofA analyst Tazeen Ahmad…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ASND Ascendis Pharma
$153.36 /

-2.89 (-1.85%)

ASND Ascendis Pharma
$153.36 /

-2.89 (-1.85%)

06:06 Today BofA
Ascendis Pharma downgraded to Neutral from Buy at BofA
08/26/21 Credit Suisse
Ascendis Pharma price target raised to $185 from $178 at Credit Suisse
08/26/21 JPMorgan
Ascendis Pharma price target raised to $175 from $172 at JPMorgan
07/27/21 Wedbush
Ascendis Pharma removed from Best Ideas List at Wedbush
ASND Ascendis Pharma
$153.36 /

-2.89 (-1.85%)

  • 02
    Sep
ASND Ascendis Pharma
$153.36 /

-2.89 (-1.85%)

Hot Stocks
Credit Suisse fined over GBP 147M by U.K.'s FCA » 06:13
10/20/21
10/20
06:13
10/20/21
06:13
CS

Credit Suisse

$10.61 /

+0.15 (+1.43%)

The Financial Conduct…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

10/19/21 Kepler Cheuvreux
Credit Suisse upgraded to Buy from Hold at Kepler Cheuvreux
09/17/21 JPMorgan
Credit Suisse price target lowered to CHF 11.30 from CHF 11.60 at JPMorgan
08/12/21 Citi
Credit Suisse removed from EMEA Focus List at Citi
07/30/21 Barclays
Credit Suisse price target raised to CHF 12.50 from CHF 12 at Barclays
CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

Recommendations
Macy's spinning e-commerce unit does not make sense strategically, says Citi » 06:12
10/20/21
10/20
06:12
10/20/21
06:12
M

Macy's

$26.54 /

-1.705 (-6.04%)

Citi analyst Paul Lejuez…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
M Macy's
$26.54 /

-1.705 (-6.04%)

M Macy's
$26.54 /

-1.705 (-6.04%)

09/28/21
Fly Intel: Top five analyst upgrades
09/28/21 Gordon Haskett
Macy's upgraded to Buy from Hold at Gordon Haskett
09/09/21 Cowen
Cowen upgrades Macy's to Outperform, sees 'American icon reinvented'
09/09/21
Fly Intel: Top five analyst upgrades
M Macy's
$26.54 /

-1.705 (-6.04%)

M Macy's
$26.54 /

-1.705 (-6.04%)

M Macy's
$26.54 /

-1.705 (-6.04%)

M Macy's
$26.54 /

-1.705 (-6.04%)

Hot Stocks
High Tide to transition cannabis retail stores to cannabis discount club concept » 06:12
10/20/21
10/20
06:12
10/20/21
06:12
HITI

High Tide

$5.99 /

+0.215 (+3.72%)

High Tide announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HITI High Tide
$5.99 /

+0.215 (+3.72%)

HITI High Tide
$5.99 /

+0.215 (+3.72%)

10/07/21 Roth Capital
Roth Capital views High Tide acquisition of Blessed CBD 'favorably'
09/13/21 Roth Capital
High Tide initiated with a Buy rating at Roth Capital
09/02/21 Desjardins
High Tide initiated with a Buy at Desjardins
HITI High Tide
$5.99 /

+0.215 (+3.72%)

HITI High Tide
$5.99 /

+0.215 (+3.72%)

Downgrade
Netflix downgraded to Hold from Buy at Deutsche Bank » 06:11
10/20/21
10/20
06:11
10/20/21
06:11
NFLX

Netflix

$639.47 /

+1.62 (+0.25%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$639.47 /

+1.62 (+0.25%)

NFLX Netflix
$639.47 /

+1.62 (+0.25%)

04:58 Today Piper Sandler
Netflix Q4 content slate 'still looks compelling,' says Piper Sandler
04:51 Today Pivotal Research
Netflix price target raised to $750 from $700 at Pivotal Research
10/19/21 Truist
Netflix's Q3 results 'very solid', says Truist
10/18/21 Loop Capital
Netflix price target raised to $700 from $650 at Loop Capital
NFLX Netflix
$639.47 /

+1.62 (+0.25%)

NFLX Netflix
$639.47 /

+1.62 (+0.25%)

NFLX Netflix
$639.47 /

+1.62 (+0.25%)

NFLX Netflix
$639.47 /

+1.62 (+0.25%)

Hot Stocks
Credit Suisse to pay nearly $100M to SEC to resolve Mozambique charges » 06:11
10/20/21
10/20
06:11
10/20/21
06:11
CS

Credit Suisse

$10.61 /

+0.15 (+1.43%)

Credit Suisse Group AG…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

10/19/21 Kepler Cheuvreux
Credit Suisse upgraded to Buy from Hold at Kepler Cheuvreux
09/17/21 JPMorgan
Credit Suisse price target lowered to CHF 11.30 from CHF 11.60 at JPMorgan
08/12/21 Citi
Credit Suisse removed from EMEA Focus List at Citi
07/30/21 Barclays
Credit Suisse price target raised to CHF 12.50 from CHF 12 at Barclays
CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

Hot Stocks
Matador provides operational update » 06:11
10/20/21
10/20
06:11
10/20/21
06:11
MTDR

Matador

$43.00 /

-0.84 (-1.92%)

Matador provided an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MTDR Matador
$43.00 /

-0.84 (-1.92%)

MTDR Matador
$43.00 /

-0.84 (-1.92%)

10/13/21 Wells Fargo
Matador price target raised to $46 from $40 at Wells Fargo
10/07/21 Truist
Matador price target raised to $54 from $50 at Truist
09/15/21
Fly Intel: Top five analyst upgrades
09/15/21 JPMorgan
Matador upgraded to Overweight from Neutral at JPMorgan
MTDR Matador
$43.00 /

-0.84 (-1.92%)

MTDR Matador
$43.00 /

-0.84 (-1.92%)

Hot Stocks
Trade Desk announces advertising partnership with Xiaomi » 06:09
10/20/21
10/20
06:09
10/20/21
06:09
TTD

Trade Desk

$81.39 /

+0.545 (+0.67%)

, XIACF

Xiaomi

$2.93 /

+0.18 (+6.55%)

The Trade Desk (TTD)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TTD Trade Desk
$81.39 /

+0.545 (+0.67%)

XIACF Xiaomi
$2.93 /

+0.18 (+6.55%)

TTD Trade Desk
$81.39 /

+0.545 (+0.67%)

10/04/21 Vertical Group
Trade Desk downgraded to Neutral from Buy at Vertical Group
09/30/21 Cleveland Research
Trade Desk initiated with a Buy at Cleveland Research
09/22/21 Berenberg
Trade Desk assumed with a Buy at Berenberg
08/17/21 Citi
Trade Desk price target raised to $85 from $60 at Citi
XIACF Xiaomi
$2.93 /

+0.18 (+6.55%)

03/16/21 Citi
Xiaomi upgraded to Buy from Sell at Citi
03/16/21 HSBC
Xiaomi upgraded to Buy from Hold at HSBC
11/25/20 Macquarie
Xiaomi downgraded to Underperform from Neutral at Macquarie
11/25/20 Daiwa
Xiaomi downgraded to Hold from Buy at Daiwa
TTD Trade Desk
$81.39 /

+0.545 (+0.67%)

XIACF Xiaomi
$2.93 /

+0.18 (+6.55%)

TTD Trade Desk
$81.39 /

+0.545 (+0.67%)

TTD Trade Desk
$81.39 /

+0.545 (+0.67%)

Hot Stocks
Credit Suisse resolves fraudulent Mozambique loan case in global resolution » 06:09
10/20/21
10/20
06:09
10/20/21
06:09
CS

Credit Suisse

$10.61 /

+0.15 (+1.43%)

Credit Suisse, a global…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

10/19/21 Kepler Cheuvreux
Credit Suisse upgraded to Buy from Hold at Kepler Cheuvreux
09/17/21 JPMorgan
Credit Suisse price target lowered to CHF 11.30 from CHF 11.60 at JPMorgan
08/12/21 Citi
Credit Suisse removed from EMEA Focus List at Citi
07/30/21 Barclays
Credit Suisse price target raised to CHF 12.50 from CHF 12 at Barclays
CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

Initiation
Compass Therapeutics initiated with a Buy at H.C. Wainwright » 06:07
10/20/21
10/20
06:07
10/20/21
06:07
CMPX

Compass Therapeutics

$3.25 /

+0.05 (+1.56%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CMPX Compass Therapeutics
$3.25 /

+0.05 (+1.56%)

10/01/21 Benchmark
Compass Therapeutics initiated with a Speculative Buy at Benchmark
  • 13
    Nov
Hot Stocks
Enviva, GreenGasUSA announce 10-year renewable natural gas agreement » 06:07
10/20/21
10/20
06:07
10/20/21
06:07
EVA

Enviva

$65.69 /

+0.2 (+0.31%)

Enviva Partners and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EVA Enviva
$65.69 /

+0.2 (+0.31%)

EVA Enviva
$65.69 /

+0.2 (+0.31%)

10/18/21 RBC Capital
Enviva price target raised to $75 from $60 at RBC Capital
10/18/21 Barclays
Enviva price target raised to $80 from $67 at Barclays
10/05/21 Raymond James
Enviva downgraded to Outperform from Strong Buy at Raymond James
09/07/21 JPMorgan
Enviva initiated with Overweight, $63 price target at JPMorgan
EVA Enviva
$65.69 /

+0.2 (+0.31%)

  • 04
    Jun
Periodicals
Facebook plans to change name to reflect metaverse focus, The Verge reports » 06:07
10/20/21
10/20
06:07
10/20/21
06:07
FB

Facebook

$340.06 /

+4.62 (+1.38%)

Facebook is planning to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FB Facebook
$340.06 /

+4.62 (+1.38%)

FB Facebook
$340.06 /

+4.62 (+1.38%)

10/18/21 Wedbush
Wedbush continues to favor Google, Snap headed into quarterly results
10/18/21 Credit Suisse
Facebook algorithm, service outages grab investor attention, says Credit Suisse
10/15/21 Evercore ISI
Facebook added to 'Tactical Underperform List' at Evercore ISI
10/13/21 Tigress Financial
Facebook price target raised to $466 from $430 at Tigress Financial
FB Facebook
$340.06 /

+4.62 (+1.38%)

FB Facebook
$340.06 /

+4.62 (+1.38%)

FB Facebook
$340.06 /

+4.62 (+1.38%)

FB Facebook
$340.06 /

+4.62 (+1.38%)

Downgrade
Galera Therapeutics downgraded to Neutral from Buy at H.C. Wainwright » 06:06
10/20/21
10/20
06:06
10/20/21
06:06
GRTX

Galera Therapeutics

/

+

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GRTX Galera Therapeutics
/

+

GRTX Galera Therapeutics
/

+

10/19/21 BofA
Galera double downgraded to Underperform at BofA after ROMAN trial miss
10/19/21 BofA
Galera Therapeutics downgraded to Underperform from Buy at BofA
10/19/21 BTIG
Galera Therapeutics downgraded to Neutral from Buy at BTIG
10/19/21 Roth Capital
Roth Capital bullish on Monopar Therapeutics after competitor trial fails
GRTX Galera Therapeutics
/

+

GRTX Galera Therapeutics
/

+

GRTX Galera Therapeutics
/

+

Downgrade
Ascendis Pharma downgraded to Neutral from Buy at BofA » 06:06
10/20/21
10/20
06:06
10/20/21
06:06
ASND

Ascendis Pharma

$153.36 /

-2.89 (-1.85%)

BofA analyst Tazeen Ahmad…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ASND Ascendis Pharma
$153.36 /

-2.89 (-1.85%)

ASND Ascendis Pharma
$153.36 /

-2.89 (-1.85%)

08/26/21 Credit Suisse
Ascendis Pharma price target raised to $185 from $178 at Credit Suisse
08/26/21 JPMorgan
Ascendis Pharma price target raised to $175 from $172 at JPMorgan
07/27/21 Wedbush
Ascendis Pharma removed from Best Ideas List at Wedbush
07/08/21 Canaccord
Ascendis Pharma recent selloff a buying opportunity, says Canaccord
ASND Ascendis Pharma
$153.36 /

-2.89 (-1.85%)

  • 02
    Sep
ASND Ascendis Pharma
$153.36 /

-2.89 (-1.85%)

Hot Stocks
Micron announces over $150B in manufacturing and R&D investments » 06:06
10/20/21
10/20
06:06
10/20/21
06:06
MU

Micron

$67.58 /

+0.31 (+0.46%)

Micron Technology…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MU Micron
$67.58 /

+0.31 (+0.46%)

MU Micron
$67.58 /

+0.31 (+0.46%)

06:05 Today Mizuho
Micron downgraded to Neutral from Buy at Mizuho
10/19/21 Mizuho
Micron downgraded to Neutral from Buy at Mizuho
10/15/21 BofA
Micron reinstated with a Neutral at BofA
10/15/21 BofA
Micron reinstated with a Neutral at BofA
MU Micron
$67.58 /

+0.31 (+0.46%)

MU Micron
$67.58 /

+0.31 (+0.46%)

MU Micron
$67.58 /

+0.31 (+0.46%)

MU Micron
$67.58 /

+0.31 (+0.46%)

Downgrade
Micron downgraded to Neutral from Buy at Mizuho » 06:05
10/20/21
10/20
06:05
10/20/21
06:05
MU

Micron

$67.58 /

+0.31 (+0.46%)

Mizuho analyst Vijay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MU Micron
$67.58 /

+0.31 (+0.46%)

MU Micron
$67.58 /

+0.31 (+0.46%)

10/19/21 Mizuho
Micron downgraded to Neutral from Buy at Mizuho
10/15/21 BofA
Micron reinstated with a Neutral at BofA
10/15/21 BofA
Micron reinstated with a Neutral at BofA
10/14/21 Goldman Sachs
Micron price target lowered to $88 from $104 at Goldman Sachs
MU Micron
$67.58 /

+0.31 (+0.46%)

MU Micron
$67.58 /

+0.31 (+0.46%)

MU Micron
$67.58 /

+0.31 (+0.46%)

MU Micron
$67.58 /

+0.31 (+0.46%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.